Innovation Spotlight

PHAXTEC is a fast-growing start-up commercializing polyhydroxyalkanoates (PHA)—a breakthrough natural biomaterial to replace fossil-based, non-biodegradable plastics. Its patent-protected process converts renewable and waste greenhouse gases into PHA, unlocking sustainable solutions for packaging, personal care, agriculture, textiles, automotive, and more. PHA can replace over 50% of the world’s fossil plastics.

Onconaut Therapeutics develops breakthrough cancer therapies that target CHD1L, an oncogenic driver in colorectal and other metastatic cancers. Onconaut’s CHD1L inhibitors halt tumor progression, inhibit metastatic spread, induce PARthanatos—a unique form of cell death—and synergize with existing treatments, offering transformative, life-extending options for patients facing limited and ineffective therapies.

Alta Biotech provides a broad range of molecular biology services with a core specialization in high-quality plasmid DNA preparation, supporting research, therapeutic development, and diagnostics across biotech and pharmaceutical industries.

Pathways Bioscience is a health-focused company that enhances wellness through science-backed supplements like PB125®. With Nrf2-activating ingredients, the company supports individuals in managing oxidative stress and promoting healthy aging, while advancing research in cellular health and longevity.

RefinedScience team of experts in clinical medicine, molecular and cellular biology, data science and pharma turn insights into advancements in care. Through the power of big data, single cell omics and AI RefinedScience aim to identify effective therapies, diagnostics and other key breakthroughs and deliver them to the patients who need them the most.

CPC Clinical Research (CPC) is an academic research organization recognized for its expertise in comprehensive clinical trial design and management for both national and international clinical research. CPC is a leader in innovative, efficient, and pragmatic approaches to clinical trials, implementation science, and real-world evidence studies. The team leads clinical scientific programs including clinical trials providing full service and a global reach.

Lohocla Research Corporation conceptualizes novel solutions for difficult medical problems like chronic pain, neurodegenerative disease, and addictive disorders by employing an iconoclastic approach. Deep experience undergirds the scientific expertise of the company’s executive scientists. To date, Lohocla Research has brought two first-in-class small-molecule drugs to first-in-human trials: Kindolor and Nezavist.

OncoVerity is a cutting-edge biotech company using a computational biology platform to better the lives of patients battling cancer. OncoVerity is addressing a fundamental challenge in cancer treatment—the diverse nature of cancer cells—by using single-cell analysis technology and machine learning to advance transformative cancer therapies.

EnteroTrack produces EnteroTracker®, a simple-to-use, inexpensive device to sample the upper gastrointestinal (GI) system in children and adults without the need for endoscopy. Screening or monitoring the upper GI tract is important to catch diseases early such as esophageal cancer or to control chronic conditions such as Eosinophilic Esophagitis (EoE).

GelSana engineers highly elastic wound dressing polymers which stretch and conform across any wound, reduce inflammation through polymer chemistry, prevent infection, and provide sustained drug delivery over time.